Evidence map›Paper›PMID 40901804›Full record

ArticlePloS one2025

Financial burden of cancer in Nepal: Factors associated with annual cost and catastrophic health expenditure.

Pratik Khanal, Kjell Arne Johansson, Achyut Raj Pandey, Ravi Kant Mishra, Nirmal Poudel, Sandipa Sharma, Biraj Man Karmacharya, Shiva Raj Adhikari, Krishna Kumar Aryal

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pratik KhanalBergen Centre for Ethics and Priority Setting in Health (BCEPS), Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.ORCID https://orcid.org/0000-0002-1057-5700
Kjell Arne JohanssonBergen Centre for Ethics and Priority Setting in Health (BCEPS), Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Achyut Raj PandeyBergen Centre for Ethics and Priority Setting in Health (BCEPS), Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Ravi Kant MishraBergen Centre for Ethics and Priority Setting in Health (BCEPS), Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Nirmal PoudelNepal Health Economics Association, Kathmandu, Nepal.ORCID https://orcid.org/0000-0002-1611-1149
Sandipa SharmaNepal Health Economics Association, Kathmandu, Nepal.
Biraj Man KarmacharyaDepartment of Public Health and Community Programs, Kathmandu University School of Medical Sciences, Dhulikhel, Nepal.
Shiva Raj AdhikariNepal Health Economics Association, Kathmandu, Nepal.
Krishna Kumar AryalBergen Centre for Ethics and Priority Setting in Health (BCEPS), Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is a dearth of comprehensive research on the financial burden of cancer in low-resource settings. This study aims to identify factors associated with annual cost of cancer care and catastrophic health expenditure as well as estimate the impoverishment linked with cancer treatment in Nepal.

methodsThis cross-sectional study was conducted in two tertiary public cancer hospitals of Nepal. Face-to-face interviews were conducted with 387 patients undergoing active treatment for lung, breast, cervical, stomach, and oesophagus cancers, recruited using a purposive-consecutive sampling strategy. A generalized linear model was used to identify factors associated with annual cost, while a multivariable logistic regression model was used for catastrophic health expenditure. Pen's Parade diagram was plotted to estimate impoverishment linked to cancer.

resultsThe annual average cost of cancer care was 3,687 United States Dollar (479,310 Nepalese rupees). Factors significantly associated with higher annual cancer costs included secondary and above education, treatment duration of 6-12 months and above one-year, combined treatment modalities, admission to inpatient care, and prior visits to private health facilities. Cervical cancer (compared to lung cancer) was significantly associated with lower costs. The incidence of catastrophic health expenditure was 96.9% and 83.9% at the 10% and 25% threshold of annual household expenditure, respectively. Treatment duration of 6-12 months, admission to inpatient care, and lowest to higher wealth quintiles were associated with higher odds of catastrophic health expenditure compared to treatment duration of less than six months, no admission to inpatient care, and highest wealth quintiles, respectively. Similarly, 26% of the patients experienced impoverishment associated with cancer treatment expenses.

conclusionSeeking cancer treatment posed a substantial financial risk to patients in Nepal. Most of the patients experienced catastrophic health expenditure while a quarter of the patients experienced impoverishment following cancer treatment expenses, highlighting the need for strengthened social health protection mechanisms.

Indexed as

Cost of IllnessHealth ExpendituresNeoplasmsAdultAgedCatastrophic IllnessCross-Sectional StudiesFemaleHumansMaleMiddle AgedNepalYoung Adult

Identifiers

PMID40901804
PMCPMC12407443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.